Free Trial

Xylem Inc. $XYL Shares Sold by American Century Companies Inc.

Xylem logo with Business Services background

Key Points

  • American Century Companies Inc. sold 220,036 shares of Xylem Inc., reducing its ownership by 11.9% to a total of 1,624,190 shares, valued at approximately $194 million.
  • 1.1% yield with a payout ratio of 41.56%.
  • Recent analyst ratings for Xylem have been positive, with Stifel Nicolaus raising the price target to $175.00 and a consensus rating of "Moderate Buy" from multiple analysts.
  • Looking to export and analyze Xylem data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

American Century Companies Inc. lessened its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 11.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,624,190 shares of the industrial products company's stock after selling 220,036 shares during the quarter. American Century Companies Inc. owned approximately 0.67% of Xylem worth $194,026,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in XYL. Townsquare Capital LLC grew its holdings in Xylem by 0.8% during the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock worth $1,285,000 after acquiring an additional 88 shares during the period. Bridgewater Associates LP boosted its stake in shares of Xylem by 59.6% in the fourth quarter. Bridgewater Associates LP now owns 2,482 shares of the industrial products company's stock worth $288,000 after acquiring an additional 927 shares during the last quarter. Evergreen Capital Management LLC boosted its stake in shares of Xylem by 3.6% in the fourth quarter. Evergreen Capital Management LLC now owns 5,585 shares of the industrial products company's stock worth $648,000 after acquiring an additional 193 shares during the last quarter. NewEdge Advisors LLC boosted its stake in shares of Xylem by 2.9% in the fourth quarter. NewEdge Advisors LLC now owns 4,019 shares of the industrial products company's stock worth $466,000 after acquiring an additional 112 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co lifted its position in Xylem by 14.3% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 394,953 shares of the industrial products company's stock worth $45,803,000 after buying an additional 49,460 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Up 0.6%

Shares of NYSE:XYL traded up $0.87 on Tuesday, hitting $141.72. 1,177,045 shares of the company's stock were exchanged, compared to its average volume of 1,472,466. The firm's 50-day moving average is $133.08 and its 200 day moving average is $126.01. The company has a market capitalization of $34.50 billion, a PE ratio of 36.81, a P/E/G ratio of 2.44 and a beta of 1.11. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio is 41.56%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. JPMorgan Chase & Co. assumed coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price objective on the stock. UBS Group lifted their target price on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research report on Tuesday, August 5th. Wall Street Zen upgraded Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Citigroup restated a "buy" rating and issued a $152.00 target price (up previously from $137.00) on shares of Xylem in a research report on Monday, July 14th. Finally, Royal Bank Of Canada lifted their target price on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research report on Wednesday, April 30th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Xylem presently has a consensus rating of "Moderate Buy" and an average target price of $151.57.

Get Our Latest Report on XYL

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines